Clinical Laserthermia Systems Stock Fundamentals
| CLS-B Stock | SEK 2.98 0.32 9.70% |
Clinical Laserthermia Systems fundamentals help investors to digest information that contributes to Clinical Laserthermia's financial success or failures. It also enables traders to predict the movement of Clinical Stock. The fundamental analysis module provides a way to measure Clinical Laserthermia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Clinical Laserthermia stock.
Clinical |
Clinical Laserthermia Systems Company Current Valuation Analysis
Clinical Laserthermia's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Clinical Laserthermia Current Valuation | 73.29 M |
Most of Clinical Laserthermia's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clinical Laserthermia Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Clinical Laserthermia Systems has a Current Valuation of 73.29 M. This is 99.49% lower than that of the Healthcare sector and 99.41% lower than that of the Medical Devices industry. The current valuation for all Sweden stocks is 99.56% higher than that of the company.
Clinical Laserthermia Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Clinical Laserthermia's current stock value. Our valuation model uses many indicators to compare Clinical Laserthermia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clinical Laserthermia competition to find correlations between indicators driving Clinical Laserthermia's intrinsic value. More Info.Clinical Laserthermia Systems is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Clinical Laserthermia's earnings, one of the primary drivers of an investment's value.Clinical Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clinical Laserthermia's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clinical Laserthermia could also be used in its relative valuation, which is a method of valuing Clinical Laserthermia by comparing valuation metrics of similar companies.Clinical Laserthermia is currently under evaluation in current valuation category among its peers.
Clinical Fundamentals
| Return On Equity | -2.59 | |||
| Return On Asset | -0.66 | |||
| Operating Margin | (23.95) % | |||
| Current Valuation | 73.29 M | |||
| Shares Outstanding | 134.52 M | |||
| Shares Owned By Insiders | 9.70 % | |||
| Shares Owned By Institutions | 2.27 % | |||
| Price To Earning | (10.13) X | |||
| Price To Book | 4.26 X | |||
| Price To Sales | 28.92 X | |||
| Revenue | 2.25 M | |||
| Gross Profit | (3.63 M) | |||
| EBITDA | (54.42 M) | |||
| Net Income | (63.62 M) | |||
| Cash And Equivalents | 13.5 M | |||
| Cash Per Share | 0.39 X | |||
| Total Debt | 100 K | |||
| Debt To Equity | 3.20 % | |||
| Current Ratio | 3.61 X | |||
| Book Value Per Share | 0.18 X | |||
| Cash Flow From Operations | (66.17 M) | |||
| Earnings Per Share | (1.08) X | |||
| Target Price | 1.4 | |||
| Number Of Employees | 12 | |||
| Beta | 0.78 | |||
| Market Capitalization | 104.76 M | |||
| Total Asset | 66.74 M | |||
| Retained Earnings | (88 M) | |||
| Working Capital | 14 M | |||
| Current Asset | 22 M | |||
| Current Liabilities | 8 M | |||
| Net Asset | 66.74 M |
About Clinical Laserthermia Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clinical Laserthermia Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clinical Laserthermia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clinical Laserthermia Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Clinical Laserthermia Systems AB develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. Clinical Laserthermia Systems AB has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring and a collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery. Clinical Laserthermia is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clinical Stock Analysis
When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.